Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma Clinical Trials in Beijing, Beijing Municipality

A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma